Global Tumor Blood Testing Market Report 2025

Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Tumor Blood Testing Global Market Report 2025

Name: Tumor Blood Testing Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Test Type (Circulating Tumor Cells (CTC) Tests, Circulating Tumor DNA (CtDNA) Tests, Exosome-Based Tests, Other Test Types); By Technology (Polymerase Chain Reaction (PCR)-Based Testing); By Cancer Type (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Melanoma); By Application (Early Cancer Screening, Therapy Selection); By End User (Hospitals, Other End-Users); Subsegments:; By Circulating Tumor Cells Tests (Isolation Of Tumor Cells); By Circulating Tumor DNA Tests (Mutation Detection Of Tumor DNA, Fragmentation Analysis Of Tumor DNA); By Exosome-Based Tests (Protein Profiling Of Exosomes); By Other Tests (Circulating RNA Tests, Immuno Oncology Biomarker Tests) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tumor Blood Testing Market Overview

• Tumor Blood Testing market size has reached to $5.27 billion in 2024

• Expected to grow to $9.83 billion in 2029 at a compound annual growth rate (CAGR) of 13.2%

• Growth Driver: Rise In Cancer Prevalence Driving The Growth Of The Market Due To Increasing Demand For Early Detection And Improved Patient Outcomes

• Market Trend: Focus On Non-Invasive Liquid Biopsy Technologies Driving Innovation And Efficiency In The Market

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Tumor Blood Testing Market?

Tumor blood testing is a diagnostic technique that examines a blood sample to identify cancer-related biomarkers. It primarily detects genetic material released by tumors, such as circulating tumor DNA (ctDNA), providing a minimally invasive alternative to traditional tissue biopsies for cancer detection and monitoring. This method enables earlier diagnosis, continuous disease monitoring, and more informed treatment decisions.

The main types of tests in the tumor blood testing market are circulating tumor cells (CTC) tests, circulating tumor DNA (CtDNA) tests, exosome-based tests, and others. Circulating tumor cells (CTC) tests refer to diagnostic tests that detect and analyze cancer cells that have detached from a primary tumor and are circulating in the bloodstream. The various technologies include polymerase chain reaction (PCR)-based testing, next-generation sequencing, microarray-based testing, mass spectrometry and immunoassays. The various types of cancers tested are breast cancer, colorectal cancer, lung cancer, prostate cancer, and melanoma. The key applications include early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring. The primary end users are hospitals, diagnostic laboratories, research institutes, and others.

Tumor Blood Testing Market Size and growth rate 2025 to 2029: Graph

What Is The Tumor Blood Testing Market Size 2025 And Growth Rate?

What Is The Tumor Blood Testing Market Growth Forecast?

The tumor blood testing market size is expected to see rapid growth in the next few years. It will grow to $9.83 billion in 2029 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to the rise in the use of point-of-care testing solutions, the increase in clinical validation of novel blood tests, the rise in government and private funding for cancer research, the increase in the availability of high-sensitivity tumor biomarkers, and the rise in patient preference for less invasive procedures. Major trends in the forecast period include innovation in multi-cancer early detection (MCED) tests, advancement in companion diagnostics, innovation in synthetic biology applications in diagnostics, integration of blockchain for data security in diagnostics, and integration of robotics in laboratory processes.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Medical Equipment Industry?

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

How the Tumor Blood Testing Market Segmented?

1) By Test Type: Circulating Tumor Cells (CTC) Tests, Circulating Tumor DNA (CtDNA) Tests, Exosome-Based Tests, Other Test Types

2) By Technology: Polymerase Chain Reaction (PCR)-Based Testing, Next-Generation Sequencing, Microarray-Based Testing, Mass Spectrometry, Immunoassays

3) By Cancer Type: Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Melanoma

4) By Application: Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring

5) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Circulating Tumor Cells Tests: Isolation Of Tumor Cells, Enumeration Of Tumor Cells, Characterization Of Tumor Cells

2) By Circulating Tumor DNA Tests: Mutation Detection Of Tumor DNA, Methylation Analysis Of Tumor DNA, Copy Number Variation Analysis Of Tumor DNA, Fragmentation Analysis Of Tumor DNA

3) By Exosome-Based Tests: Protein Profiling Of Exosomes, RNA Profiling Of Exosomes, Lipid Profiling Of Exosomes, Surface Marker Analysis Of Exosomes

4) By Other Tests: Circulating RNA Tests, Tumor Educated Platelet Tests, Protein Biomarker Panels, Multiomics Blood Tests, Immuno Oncology Biomarker Tests

What Is Driving The Tumor Blood Testing Market? Rise In Cancer Prevalence Driving The Growth Of The Market Due To Increasing Demand For Early Detection And Improved Patient Outcomes

The increasing prevalence of cancer is expected to drive the growth of the tumor blood testing market in the coming years. Aging populations and exposure to risk factors such as poor diet, smoking, and pollution are contributing to a higher incidence of cancer, fueling demand for early detection methods. Tumor blood testing provides a minimally invasive approach to detect cancer before symptoms appear by identifying biomarkers in the bloodstream. This enables timely diagnosis, early treatment, improved patient outcomes, and ongoing monitoring of disease progression and therapy effectiveness. For instance, in May 2024, according to the National Cancer Institute, a US-based government agency, as of January 2022, the United States had an estimated 18.1 million cancer survivors, with projections expected to reach 26 million by 2040. Therefore, the increasing prevalence of cancer is driving the growth of the tumor blood testing industry.

Who Are The Major Players In The Global Tumor Blood Testing Market?

Major companies operating in the tumor blood testing market are Bio-Techne Corporation, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Natera Inc., Myriad Genetics Inc., Neogenomics Laboratories Inc., Guardant Health Inc., Foundation Medicine Inc., Adaptive Biotechnologies Corporation, Freenome Holdings Inc., Grail Inc., Personal Genome Diagnostics Inc., Exosome Diagnostics Inc., Agena Bioscience Inc., Menarini Silicon Biosystems S.p.A.

What Are The Key Trends Of The Global Tumor Blood Testing Market? Focus On Non-Invasive Liquid Biopsy Technologies Driving Innovation And Efficiency In The Market

Major companies operating in the tumor blood testing market are focusing on developing innovative technology such as, non-invasive liquid biopsy technologies to enable early cancer detection, monitor treatment response, and assess disease progression more efficiently. Non-invasive liquid biopsy technologies are diagnostic tests that detect and analyze cancer-related biomarkers from bodily fluids, providing a safer and more convenient alternative to traditional tissue biopsies. For instance, in February 2024, Delfi Diagnostics, a US-based biotechnology company, in collaboration with Immunocore Holdings plc, a UK-based biotechnology company, launched the DELFI-Tumor Fraction (DELFI-TF) assay, a cancer-monitoring blood test. It analyzes cell-free DNA (cfDNA) fragments in the bloodstream to assess tumor burden and treatment response. This fragmentome-based liquid biopsy offers a non-invasive, cost-effective alternative to traditional methods, requiring minimal plasma and providing results within two weeks.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Tumor Blood Testing Market? TG Therapeutics Enters Strategic Partnership with Neuraxpharm for Ex-U.S. Commercialization of BRIUMVI

In August 2025, Exact Sciences Corp., a US-based diagnostics and biotechnology company, acquired the rights to a blood-based colon cancer screening test from Freenome Holdings Inc. for an undisclosed amount. Through this acquisition, Exact Sciences Corp aims to strengthen its position in the early cancer detection market and expand its technological capabilities by incorporating Freenome Holdings, Inc.’s advanced multiomics and AI-driven blood testing platform. Freenome Holdings Inc. is a US-based biotechnology company focused on developing blood tests to detect cancer early.

What Is The Regional Outlook For The Global Tumor Blood Testing Market?

North America was the largest region in the tumor blood testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Tumor Blood Testing Market?

The tumor blood testing market consists of revenues earned by entities by providing services such as liquid biopsy testing services, early cancer detection services, clinical trial support services, genetic mutation profiling services, and cancer biomarker screening services. The market value includes the value of related goods sold by the service provider or included within the service offering. The tumor blood testing market also includes sales of exosome isolation kits, immunoassay kits, microfluidic devices, epigenetic assay kits, and protein biomarker panels. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Tumor Blood Testing Industry?

The tumor blood testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the tumor blood testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

1. Executive Summary

2. Tumor Blood Testing Market Characteristics

3. Tumor Blood Testing Market Trends And Strategies

4. Tumor Blood Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Tumor Blood Testing Growth Analysis And Strategic Analysis Framework

5.1. Global Tumor Blood Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Tumor Blood Testing Market Growth Rate Analysis

5.4. Global Tumor Blood Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Tumor Blood Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Tumor Blood Testing Total Addressable Market (TAM)

6. Tumor Blood Testing Market Segmentation

6.1. Global Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Circulating Tumor Cells (CTC) Tests

Circulating Tumor DNA (CtDNA) Tests

Exosome-Based Tests

Other Test Types

6.2. Global Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Polymerase Chain Reaction (PCR)-Based Testing

Next-Generation Sequencing

Microarray-Based Testing

Mass Spectrometry

Immunoassays

6.3. Global Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Breast Cancer

Colorectal Cancer

Lung Cancer

Prostate Cancer

Melanoma

6.4. Global Tumor Blood Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Early Cancer Screening

Therapy Selection

Treatment Monitoring

Recurrence Monitoring

6.5. Global Tumor Blood Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Diagnostic Laboratories

Research Institutes

Other End-Users

6.6. Global Tumor Blood Testing Market, Sub-Segmentation Of Circulating Tumor Cells Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Isolation Of Tumor Cells

Enumeration Of Tumor Cells

Characterization Of Tumor Cells

6.7. Global Tumor Blood Testing Market, Sub-Segmentation Of Circulating Tumor DNA Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Mutation Detection Of Tumor DNA

Methylation Analysis Of Tumor DNA

Copy Number Variation Analysis Of Tumor DNA

Fragmentation Analysis Of Tumor DNA

6.8. Global Tumor Blood Testing Market, Sub-Segmentation Of Exosome-Based Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Protein Profiling Of Exosomes

RNA Profiling Of Exosomes

Lipid Profiling Of Exosomes

Surface Marker Analysis Of Exosomes

6.9. Global Tumor Blood Testing Market, Sub-Segmentation Of Other Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Circulating RNA Tests

Tumor Educated Platelet Tests

Protein Biomarker Panels

Multiomics Blood Tests

Immuno Oncology Biomarker Tests

7. Tumor Blood Testing Market Regional And Country Analysis

7.1. Global Tumor Blood Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Tumor Blood Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tumor Blood Testing Market

8.1. Asia-Pacific Tumor Blood Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tumor Blood Testing Market

9.1. China Tumor Blood Testing Market Overview

9.2. China Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tumor Blood Testing Market

10.1. India Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tumor Blood Testing Market

11.1. Japan Tumor Blood Testing Market Overview

11.2. Japan Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tumor Blood Testing Market

12.1. Australia Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tumor Blood Testing Market

13.1. Indonesia Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tumor Blood Testing Market

14.1. South Korea Tumor Blood Testing Market Overview

14.2. South Korea Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tumor Blood Testing Market

15.1. Western Europe Tumor Blood Testing Market Overview

15.2. Western Europe Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tumor Blood Testing Market

16.1. UK Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tumor Blood Testing Market

17.1. Germany Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tumor Blood Testing Market

18.1. France Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tumor Blood Testing Market

19.1. Italy Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tumor Blood Testing Market

20.1. Spain Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tumor Blood Testing Market

21.1. Eastern Europe Tumor Blood Testing Market Overview

21.2. Eastern Europe Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tumor Blood Testing Market

22.1. Russia Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tumor Blood Testing Market

23.1. North America Tumor Blood Testing Market Overview

23.2. North America Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tumor Blood Testing Market

24.1. USA Tumor Blood Testing Market Overview

24.2. USA Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tumor Blood Testing Market

25.1. Canada Tumor Blood Testing Market Overview

25.2. Canada Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tumor Blood Testing Market

26.1. South America Tumor Blood Testing Market Overview

26.2. South America Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tumor Blood Testing Market

27.1. Brazil Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tumor Blood Testing Market

28.1. Middle East Tumor Blood Testing Market Overview

28.2. Middle East Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tumor Blood Testing Market

29.1. Africa Tumor Blood Testing Market Overview

29.2. Africa Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tumor Blood Testing Market Competitive Landscape And Company Profiles

30.1. Tumor Blood Testing Market Competitive Landscape

30.2. Tumor Blood Testing Market Company Profiles

30.2.1. Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Tumor Blood Testing Market Other Major And Innovative Companies

31.1. Illumina Inc.

31.2. Sysmex Corporation

31.3. Bio-Rad Laboratories Inc.

31.4. Natera Inc.

31.5. Myriad Genetics Inc.

31.6. Neogenomics Laboratories Inc.

31.7. Guardant Health Inc.

31.8. Foundation Medicine Inc.

31.9. Adaptive Biotechnologies Corporation

31.10. Freenome Holdings Inc.

31.11. Grail Inc.

31.12. Personal Genome Diagnostics Inc.

31.13. Exosome Diagnostics Inc.

31.14. Agena Bioscience Inc.

31.15. Menarini Silicon Biosystems S.p.A.

32. Global Tumor Blood Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tumor Blood Testing Market

34. Recent Developments In The Tumor Blood Testing Market

35. Tumor Blood Testing Market High Potential Countries, Segments and Strategies

35.1 Tumor Blood Testing Market In 2029 - Countries Offering Most New Opportunities

35.2 Tumor Blood Testing Market In 2029 - Segments Offering Most New Opportunities

35.3 Tumor Blood Testing Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Tumor Blood Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Tumor Blood Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Tumor Blood Testing Market, Sub-Segmentation Of Circulating Tumor Cells Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Tumor Blood Testing Market, Sub-Segmentation Of Circulating Tumor DNA Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Tumor Blood Testing Market, Sub-Segmentation Of Exosome-Based Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Tumor Blood Testing Market, Sub-Segmentation Of Other Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Tumor Blood Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Tumor Blood Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Bio-Techne Corporation Financial Performance

Table 81: Roche Holding AG Financial Performance

Table 82: Thermo Fisher Scientific Inc. Financial Performance

Table 83: Abbott Laboratories Financial Performance

Table 84: Siemens Healthineers AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Tumor Blood Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Tumor Blood Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Tumor Blood Testing Market, Sub-Segmentation Of Circulating Tumor Cells Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Tumor Blood Testing Market, Sub-Segmentation Of Circulating Tumor DNA Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Tumor Blood Testing Market, Sub-Segmentation Of Exosome-Based Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Tumor Blood Testing Market, Sub-Segmentation Of Other Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Tumor Blood Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Tumor Blood Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Tumor Blood Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Tumor Blood Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Tumor Blood Testing Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Bio-Techne Corporation Financial Performance

Figure 81: Roche Holding AG Financial Performance

Figure 82: Thermo Fisher Scientific Inc. Financial Performance

Figure 83: Abbott Laboratories Financial Performance

Figure 84: Siemens Healthineers AG Financial Performance

Global 3D Bioprinting Market Projected to Reach $5.04 Billion by 2029 at a CAGR of 23.1%

$15.02 Billion Forecast for AI-based Surgical Robots Market by 2029, Backed by Demand and Innovation

Arrhythmia Monitoring Devices Market Forecast Reaching $12.03 Billion by 2029 at 10.2% CAGR

Autoinjectors Market Valuation Expected To Reach $9.93 Billion By 2029, Growing At A Rate Of 21.8%

Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Explore strategic insights and forecasts in the global virtual biopsy market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Global Nuclear Reactor Market.

Hemato Oncology Testing Global Market Report 2025 – By Product And Services (Assay Kits And Reagents, Services), By Cancer Type (Leukemia, Lymphoma, Multiple Myeloma, Other Cancers), By Technology (Polymerase Chain React...

Cancer Diagnostics Global Market Report 2025 – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast Cancer, Li...

Blood Screening Global Market Report 2025 – By Product (Reagents and Kits, Instruments, Software and Services), By Technology (Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blot As...

Blood Culture Tests Global Market Report 2025 – By Method (Conventional/Manual Methods, Automated Methods), By Product (Consumables, Instruments, Software and Services), By Technology (Culture-Based Technology, Molecular...

Blood Cancer Drugs Global Market Report 2025 – By Blood Cancer Type (Leukemia, Lymphoma), By Drugs (Rituxan/Mabthera (Rituximab), Gleevec/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotin...

Circulating Tumor Cells Global Market Report 2025 – By Product (Kits And Reagents, Blood Collection Tubes, Devices Or Systems), By Technology (CTC Enrichment, CTC Detection, CTC Analysis), By Specimen (Blood, Bone Marrow...

Hematocrit Test Devices Global Market Report 2025 – By Product (Hematocrit Test Meter, Hematocrit Test Analyzer, Reagents And Consumables), By Application (Anemia, Polycythemia Vera, Congenital Heart Diseases, Other Appl...

Frequently Asked Questions

What is the definition of the Tumor Blood Testing market?

How will the Tumor Blood Testing market drivers and restraints affect the market dynamics? What forces will shape the Tumor Blood Testing industry going forward?

The market major growth driver - Rise In Cancer Prevalence Driving The Growth Of The Market Due To Increasing Demand For Early Detection And Improved Patient Outcomes. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Tumor Blood Testing market?

The tumor blood testing market size has grown rapidly in recent years. It will grow from $5.27 billion in 2024 to $5.98 billion in 2025 at a compound annual growth rate (CAGR) of 13.5%. The growth in the historic period can be attributed to rising research in genomics and proteomics, increasing patient demand for rapid test results, rising development of targeted therapies requiring companion diagnostics, the growing trend of decentralized diagnostics, and rising patient preference for home-based sample collection. The tumor blood testing market size is expected to see rapid growth in the next few years. It will grow to $9.83 billion in 2029 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to the rise in the use of point-of-care testing solutions, the increase in clinical validation of novel blood tests, the rise in government and private funding for cancer research, the increase in the availability of high-sensitivity tumor biomarkers, and the rise in patient preference for less invasive procedures. Major trends in the forecast period include innovation in multi-cancer early detection (MCED) tests, advancement in companion diagnostics, innovation in synthetic biology applications in diagnostics, integration of blockchain for data security in diagnostics, and integration of robotics in laboratory processes. For further insights on this market, request a sample here

How is the Tumor Blood Testing market segmented?

The tumor blood testing market covered in this report is segmented as
1) By Test Type: Circulating Tumor Cells (CTC) Tests, Circulating Tumor DNA (CtDNA) Tests, Exosome-Based Tests, Other Test Types
2) By Technology: Polymerase Chain Reaction (PCR)-Based Testing, Next-Generation Sequencing, Microarray-Based Testing, Mass Spectrometry, Immunoassays
3) By Cancer Type: Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Melanoma
4) By Application: Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring
5) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Other End-Users Subsegments:
1) By Circulating Tumor Cells Tests: Isolation Of Tumor Cells, Enumeration Of Tumor Cells, Characterization Of Tumor Cells
2) By Circulating Tumor DNA Tests: Mutation Detection Of Tumor DNA, Methylation Analysis Of Tumor DNA, Copy Number Variation Analysis Of Tumor DNA, Fragmentation Analysis Of Tumor DNA
3) By Exosome-Based Tests: Protein Profiling Of Exosomes, RNA Profiling Of Exosomes, Lipid Profiling Of Exosomes, Surface Marker Analysis Of Exosomes
4) By Other Tests: Circulating RNA Tests, Tumor Educated Platelet Tests, Protein Biomarker Panels, Multiomics Blood Tests, Immuno Oncology Biomarker Tests For further insights on this market, request a sample here

Which region has the largest share of the Tumor Blood Testing market? What are the other regions covered in the report?

North America was the largest region in the tumor blood testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tumor blood testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Who are the major players in the Tumor Blood Testing market?

What are the key trends in the Tumor Blood Testing market?

Major trends in this market include Focus On Non-Invasive Liquid Biopsy Technologies Driving Innovation And Efficiency In The Market For further insights on this market, request a sample here.